Effects of glatiramer acetate in a spontaneous model of autoimmune neuroinflammation

American Journal of Pathology

Volumn 184, Issue 7, 2014, Pages 2056-2065

  Bittner, Stefan ^a,b   Ruck, Tobias ^a   Göbel, Kerstin ^a   Henschel, Christian ^a   Afzali, Ali Maisam ^a   Göb, Eva ^c   Müntefering, Thomas ^a   Kleinschnitz, Christoph ^c   Wiendl, Heinz ^a   Meuth, Sven G ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b Interdisciplinary Center for Clinical Research (IZKF)   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE MARKER; GAMMA INTERFERON; GLATIRAMER; PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEMYELINATION; DISEASE SEVERITY; DRUG EFFECT; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; INCIDENCE; MOUSE; MULTIPLE SCLEROSIS; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TREATMENT OUTCOME; ANIMAL; DISEASE MODEL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; IMMUNOLOGY; TRANSGENIC MOUSE;

ANIMALS; B-LYMPHOCYTES; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; MICE, TRANSGENIC; PEPTIDES; T-LYMPHOCYTES;

EID: 84903191321     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2014.03.009     Document Type: Article

References (28)

1. L.J. Scott Glatiramer acetate: A review of its use in patients with relapsing-remitting multiple sclerosis and in delaying the onset of clinically definite multiple sclerosis CNS Drugs 27 2013 971 988
2. R. Aharoni The mechanism of action of glatiramer acetate in multiple sclerosis and beyond Autoimmun Rev 12 2013 543 553
3. S. Dhib-Jalbut Mechanisms of action of interferons and glatiramer acetate in multiple sclerosis Neurology 58 Suppl 4 2002 S3 S9
4. R. Arnon, and M. Sela Immunomodulation by the copolymer glatiramer acetate J Mol Recognit 16 2003 412 421
5. A. Ben-Nun, I. Mendel, R. Bakimer, M. Fridkis-Hareli, D. Teitelbaum, R. Arnon, M. Sela, and N. Kerlero de Rosbo The autoimmune reactivity to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis is potentially pathogenic: effect of copolymer 1 on MOG-induced disease J Neurol 243 1996 S14 S22
6. R. Arnon, M. Sela, and D. Teitelbaum New insights into the mechanism of action of copolymer 1 in experimental allergic encephalomyelitis and multiple sclerosis J Neurol 243 1996 S8 S13
7. D. Teitelbaum, M. Fridkis-Hareli, R. Arnon, and M. Sela Copolymer 1 inhibits chronic relapsing experimental allergic encephalomyelitis induced by proteolipid protein (PLP) peptides in mice and interferes with PLP-specific T cell responses J Neuroimmunol 64 1996 209 217
8. R. Gold, C. Linington, and H. Lassmann Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research Brain 129 2006 1953 1971
9. G. Krishnamoorthy, H. Lassmann, H. Wekerle, and A. Holz Spontaneous opticospinal encephalomyelitis in a double-transgenic mouse model of autoimmune T cell/B cell cooperation J Clin Invest 116 2006 2385 2392
10. E. Bettelli, D. Baeten, A. Jager, R.A. Sobel, and V.K. Kuchroo Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a Devic-like disease in mice J Clin Invest 116 2006 2393 2402
11. E. Bettelli, M. Pagany, H.L. Weiner, C. Linington, R.A. Sobel, and V.K. Kuchroo Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis J Exp Med 197 2003 1073 1081
12. T. Litzenburger, R. Fässler, J. Bauer, H. Lassmann, C. Linington, H. Wekerle, and A. Iglesias B lymphocytes producing demyelinating autoantibodies: development and function in gene-targeted transgenic mice J Exp Med 188 1998 169 180
13. R. Bomprezzi, R. Schafer, V. Reese, A. Misra, T.L. Vollmer, and M. Kala Glatiramer acetate-specific antibody titres in patients with relapsing/remitting multiple sclerosis and in experimental autoimmune encephalomyelitis Scand J Immunol 74 2011 219 226
14. S. Begum-Haque, M. Christy, J. Ochoa-Reparaz, E.C. Nowak, D. Mielcarz, A. Haque, and L.H. Kasper Augmentation of regulatory B cell activity in experimental allergic encephalomyelitis by glatiramer acetate J Neuroimmunol 232 2011 136 144
15. B. Kayhan, R. Aharoni, and R. Arnon Glatiramer acetate (Copaxone) regulates nitric oxide and related cytokine secretion in experimental autoimmune encephalomyelitis Immunol Lett 88 2003 185 192
16. S. Bittner, T. Ruck, M.K. Schuhmann, A.M. Herrmann, H.M. Maati, N. Bobak, K. Göbel, F. Langhauser, D. Stegner, P. Ehling, M. Borsotto, H.C. Pape, B. Nieswandt, C. Kleinschnitz, C. Heurteaux, H.J. Galla, T. Budde, H. Wiendl, and S.G. Meuth Endothelial TWIK-related potassium channel-1 (TREK1) regulates immune-cell trafficking into the CNS Nat Med 19 2013 1161 1165
17. U. Feger, E. Tolosa, Y.H. Huang, A. Waschbisch, T. Biedermann, A. Melms, and H. Wiendl HLA-G expression defines a novel regulatory T-cell subset present in human peripheral blood and sites of inflammation Blood 110 2007 568 577
18. T.V. Lanz, S. Becker, M. Osswald, S. Bittner, M.K. Schuhmann, C.A. Opitz, S. Gaikwad, B. Wiestler, U.M. Litzenburger, F. Sahm, M. Ott, S. Iwantscheff, C. Grabitz, M. Mittelbronn, A. von Deimling, F. Winkler, S.G. Meuth, W. Wick, and M. Platten Protein kinase Cβ as a therapeutic target stabilizing blood-brain barrier disruption in experimental autoimmune encephalomyelitis Proc Natl Acad Sci USA 110 2013 14735 14740
19. T. Ruck, S. Bittner, C.C. Gross, J. Breuer, S. Albrecht, S. Korr, K. Göbel, S. Pankratz, C.M. Henschel, N. Schwab, O. Staszewski, M. Prinz, T. Kuhlmann, S.G. Meuth, and H. Wiendl CD4+NKG2D+ T cells exhibit enhanced migratory and encephalitogenic properties in neuroinflammation PLoS One 8 2013 e81455
20. G. Francosalinas, T. Cantaert, M.A. Nolte, P.P. Tak, R.A. van Lier, and D.L. Baeten Enhanced costimulation by CD70+ B cells aggravates experimental autoimmune encephalomyelitis in autoimmune mice J Neuroimmunol 255 2013 8 17
21. U. Schulze-Topphoff, S. Casazza, M. Varrin-Doyer, K. Michel, R.A. Sobel, S.L. Hauser, J.R. Oksenberg, S.S. Zamvil, and S.E. Baranzini Tob1 plays a critical role in the activation of encephalitogenic T cells in CNS autoimmunity J Exp Med 210 2013 1301 1309
22. R.M. Ransohoff Animal models of multiple sclerosis: The good, the bad and the bottom line Nat Neurosci 15 2012 1074 1077
23. H. Wekerle, K. Kojima, J. Lannes-Vieira, H. Lassmann, and C. Linington Animal models Ann Neurol 36 Suppl 1994 S47 S53
24. B. Pöllinger, G. Krishnamoorthy, K. Berer, H. Lassmann, M.R. Bösl, R. Dunn, H.S. Domingues, A. Holz, F.C. Kurschus, and H. Wekerle Spontaneous relapsing-remitting EAE in the SJL/J mouse: MOG-reactive transgenic T cells recruit endogenous MOG-specific B cells J Exp Med 206 2009 1303 1316
25. B.A. Cree, D.S. Goodin, and S.L. Hauser Neuromyelitis optica Semin Neurol 22 2002 105 122
26. K. Berer, M. Mues, M. Koutrolos, Z.A. Rasbi, M. Boziki, C. Johner, H. Wekerle, and G. Krishnamoorthy Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination Nature 479 2011 538 541
27. D.A. Hafler, J.M. Slavik, D.E. Anderson, K.C. O'Connor, P. De Jager, and C. Baecher-Allan Multiple sclerosis Immunol Rev 204 2005 208 231
28. K. Berer, H. Wekerle, and G. Krishnamoorthy B cells in spontaneous autoimmune diseases of the central nervous system Mol Immunol 48 2011 1332 1337